Global Proteomics Market Expected To Be Worth US$ 31 Billion By 2022

In this report, the global proteomics market is segmented by equipment, application, service, and region. Based on equipment, the market is segmented into chromatography, protein microarray, mass spectroscopy, protein fractionation, x-ray crystallography, and others. The protein fractionation segment is expected to witness the highest growth rate during the forecast period. The market, on the basis of application, is segmented into drug discovery, clinical diagnosis, and others. The proteomics market in the clinical diagnosis application is the largest. Based on service, the market is segmented into laboratory service and data analysis and services. The market is expected to witness significant growth in laboratory service.

The global proteomics market is expected to reach US$ 31 billion by 2022, registering a CAGR of 11.0% during the forecast period.

A glimpse of the report structure is provided in the report description available on the website.
https://www.marketresearchengine.com/reportdetails/proteomics-market-report

Agilent Technologies Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Danaher Corporation (U.S.), Genzyme Corporation (U.S.), GE Healthcare (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and Affymetrix Inc. (U.S.) are the active players in the proteomics market. A competitive landscape of these players with their strategies and products are provided in the report.

This report covers the proteomics market, in terms of value, and forecasts the market size till 2022. It includes the market segmentation by equipment, service, application, and region. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the market share and company profiles of the key players in the global market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.

Increasing demand for customized medicine, rising genetic and birth disorders, expanded subsidizing for proteomics ventures, and technical advancements are mainly driving the market. In addition, the rapid growth of the biopharmaceutical and pharmaceutical industry is driving the market. However, a few significant factors hampering the growth of the market are the lessened finances in key markets, decreased assets for R&D of proteomics, the high cost of equipment, and lack of professional researchers.

Request Free Sample Report: https://www.marketresearchengine.com/reportdetails/proteomics-market-report

The global proteomics market is also segmented on the basis of key regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Furthermore, each region is segmented to provide market revenue for select countries such as the U.S., Canada, the U.K. Germany, China, Japan, India, Brazil, and GCC countries. The report includes a detailed study of global and regional proteomics market and analyzes the variations in the growth of the industry in certain regions.

Table of Contents

1 INTRODUCTION
2 Research Methodology
2.1 Research Approach
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Proteomics Market Size Estimation
2.3 Proteomics Market Breakdown and Data Triangulation
2.4 Proteomics Market Share Estimation
2.5 Assumptions for the Study
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Biomarkers Market, By Product
7 Biomarkers Market, By Type
8 Biomarkers Market, By Application
9 Biomarkers Market, By Disease Indication
10 Biomarkers Market, By Region
11 Competitive Landscape
12 Company Profiles
12.1 Qiagen N.V.
12.2 Perkinelmer, Inc.
12.3 Merck Millipore
12.4 Bio-Rad Laboratories, Inc.
12.5 Enzo Biochem, Inc.
12.6 EKF Diagnostics Holdings, Inc.
12.7 Meso Scale Diagnostics, LLC.
12.8 Biosims Technologies Sas
12.9 Cisbio Bioassays
12.10 Signosis, Inc.

About Us

Market Research Engine (MRE) is a next-generation provider of syndicated research, customized research, and consulting services. MRE’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each Market Research Engine’s research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.